APO Research
Talk to an analyst

APO RESEARCH · REPORT

4 Factor Pro-thrombin Complex Concentrate

4 Factor Pro-thrombin Complex Concentrate refers to medicinal, supplement or research preparations identified by the named composition or biological target.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Identity, formulation, stock form, controls and documented use define the preparation; market categories and images do not establish approval, dosing or patient suitability.

What turns activity into demand

Distinguish equipment procurement, recurring materials and any related service within the selected study. Research use, educational use and clinical use have different acceptance requirements and should not be treated as one demand measure.

The commercial boundary

Separate research materials, devices and services within the selected edition. Approvals, labelled use and clinical acceptance need their own evidence; no medical suitability follows from this illustration.

Which supplied scope and interfaces define 4 Factor Pro-thrombin Complex Concentrate?

Identity, formulation, stock form, controls and documented use define the preparation; market categories and images do not establish approval, dosing or patient suitability.

Technical reading

Selected research

Market Structure

Global 4 Factor Pro-thrombin Complex Concentrate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025174 pages

Choose your research edition.

Industry Research4 Factor Pro-thrombin Complex Concentrate Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal 4 Factor Pro-thrombin Complex Concentrate Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal 4 Factor Pro-thrombin Complex Concentrate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal 4 Factor Pro-thrombin Complex Concentrate Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal 4 Factor Pro-thrombin Complex Concentrate Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global 4 Factor Pro-thrombin Complex Concentrate market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for 4 Factor Pro-thrombin Complex Concentrate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for 4 Factor Pro-thrombin Complex Concentrate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for 4 Factor Pro-thrombin Complex Concentrate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for 4 Factor Pro-thrombin Complex Concentrate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of 4 Factor Pro-thrombin Complex Concentrate include Takeda, Prothya Biosolutions, Octapharma and CSL Behring, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global 4 Factor Pro-thrombin Complex Concentrate market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of 4 Factor Pro-thrombin Complex Concentrate and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents 4 Factor Pro-thrombin Complex Concentrate sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the 4 Factor Pro-thrombin Complex Concentrate market size, projected growth trends, production technologies, key applications, and end-use industries.

4 Factor Pro-thrombin Complex Concentrate Segment by Company

Takeda

Prothya Biosolutions

Octapharma

CSL Behring

4 Factor Pro-thrombin Complex Concentrate Segment by Type

Prothromplex

Octaplex

Cofact

Beriplex

Other

4 Factor Pro-thrombin Complex Concentrate Segment by Application

Hemophilia B

Acquired Coagulation Factor Deficiency

4 Factor Pro-thrombin Complex Concentrate Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 4 Factor Pro-thrombin Complex Concentrate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of 4 Factor Pro-thrombin Complex Concentrate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 4 Factor Pro-thrombin Complex Concentrate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the 4 Factor Pro-thrombin Complex Concentrate market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of 4 Factor Pro-thrombin Complex Concentrate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of 4 Factor Pro-thrombin Complex Concentrate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of 4 Factor Pro-thrombin Complex Concentrate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. 4 Factor Pro-thrombin Complex Concentrate Industry Trends Table 2. 4 Factor Pro-thrombin Complex Concentrate Industry Drivers Table 3. 4 Factor Pro-thrombin Complex Concentrate Industry Opportunities and Challenges Table 4. 4 Factor Pro-thrombin Complex Concentrate Industry Restraints Table 5. Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global 4 Factor Pro-thrombin Complex Concentrate Revenue Market Share by Manufacturers (2021-2026) Table 7. Global 4 Factor Pro-thrombin Complex Concentrate Sales by Manufacturers (k units) & (2021-2026) Table 8. Global 4 Factor Pro-thrombin Complex Concentrate Sales Market Share by Manufacturers Table 9. Global 4 Factor Pro-thrombin Complex Concentrate Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global 4 Factor Pro-thrombin Complex Concentrate Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global 4 Factor Pro-thrombin Complex Concentrate Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global 4 Factor Pro-thrombin Complex Concentrate Manufacturers, Product Type & Application Table 13. Global 4 Factor Pro-thrombin Complex Concentrate Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global 4 Factor Pro-thrombin Complex Concentrate by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Prothromplex Table 17. Major Manufacturers of Octaplex Table 18. Major Manufacturers of Cofact Table 19. Major Manufacturers of Beriplex Table 20. Major Manufacturers of Other Table 21. Global 4 Factor Pro-thrombin Complex Concentrate Sales by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global 4 Factor Pro-thrombin Complex Concentrate Sales by Type (2021-2026) & (k units) Table 23. Global 4 Factor Pro-thrombin Complex Concentrate Sales by Type (2027-2032) & (k units) Table 24. Global 4 Factor Pro-thrombin Complex Concentrate Sales Market Share by Type (2021-2026) Table 25. Global 4 Factor Pro-thrombin Complex Concentrate Sales Market Share by Type (2027-2032) Table 26. Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 27. Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Type (2021-2026) & (k units) Table 28. Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Type (2027-2032) & (k units) Table 29. Global 4 Factor Pro-thrombin Complex Concentrate Revenue Market Share by Type (2021-2026) Table 30. Global 4 Factor Pro-thrombin Complex Concentrate Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Hemophilia B Table 32. Major Manufacturers of Acquired Coagulation Factor Deficiency Table 33. Global 4 Factor Pro-thrombin Complex Concentrate Sales by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global 4 Factor Pro-thrombin Complex Concentrate Sales by Application (2021-2026) & (k units) Table 35. Global 4 Factor Pro-thrombin Complex Concentrate Sales by Application (2027-2032) & (k units) Table 36. Global 4 Factor Pro-thrombin Complex Concentrate Sales Market Share by Application (2021-2026) Table 37. Global 4 Factor Pro-thrombin Complex Concentrate Sales Market Share by Application (2027-2032) Table 38. Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Application (2021-2026) & (k units) Table 40. Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Application (2027-2032) & (k units) Table 41. Global 4 Factor Pro-thrombin Complex Concentrate Revenue Market Share by Application (2021-2026) Table 42. Global 4 Factor Pro-thrombin Complex Concentrate Revenue Market Share by Application (2027-2032) Table 43. Global 4 Factor Pro-thrombin Complex Concentrate Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global 4 Factor Pro-thrombin Complex Concentrate Sales by Region (2021-2026) & (k units) Table 45. Global 4 Factor Pro-thrombin Complex Concentrate Sales Market Share by Region (2021-2026) Table 46. Global 4 Factor Pro-thrombin Complex Concentrate Sales Forecasted by Region (2027-2032) & (k units) Table 47. Global 4 Factor Pro-thrombin Complex Concentrate Sales Forecasted Market Share by Region (2027-2032) Table 48. North America 4 Factor Pro-thrombin Complex Concentrate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. North America 4 Factor Pro-thrombin Complex Concentrate Sales by Country (2021-2026) & (k units) Table 50. North America 4 Factor Pro-thrombin Complex Concentrate Sales by Country (2027-2032) & (k units) Table 51. Europe 4 Factor Pro-thrombin Complex Concentrate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Europe 4 Factor Pro-thrombin Complex Concentrate Sales by Country (2021-2026) & (k units) Table 53. Europe 4 Factor Pro-thrombin Complex Concentrate Sales by Country (2027-2032) & (k units) Table 54. Asia Pacific 4 Factor Pro-thrombin Complex Concentrate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Asia Pacific 4 Factor Pro-thrombin Complex Concentrate Sales by Country (2021-2026) & (k units) Table 56. Asia Pacific 4 Factor Pro-thrombin Complex Concentrate Sales by Country (2027-2032) & (k units) Table 57. South America, Middle East and Africa 4 Factor Pro-thrombin Complex Concentrate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. South America, Middle East and Africa 4 Factor Pro-thrombin Complex Concentrate Sales by Country (2021-2026) & (k units) Table 59. South America, Middle East and Africa 4 Factor Pro-thrombin Complex Concentrate Sales by Country (2027-2032) & (k units) Table 60. Global 4 Factor Pro-thrombin Complex Concentrate Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Region (2021-2026) & (US$ Million) Table 62. Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Region (2027-2032) & (US$ Million) Table 63. Global 4 Factor Pro-thrombin Complex Concentrate Revenue Market Share by Region (2021-2026) Table 64. Global 4 Factor Pro-thrombin Complex Concentrate Revenue Market Share by Region (2027-2032) Table 65. Takeda Company Information Table 66. Takeda Business Overview Table 67. Takeda 4 Factor Pro-thrombin Complex Concentrate Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Takeda 4 Factor Pro-thrombin Complex Concentrate Product Portfolio Table 69. Takeda Recent Development Table 70. Prothya Biosolutions Company Information Table 71. Prothya Biosolutions Business Overview Table 72. Prothya Biosolutions 4 Factor Pro-thrombin Complex Concentrate Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Prothya Biosolutions 4 Factor Pro-thrombin Complex Concentrate Product Portfolio Table 74. Prothya Biosolutions Recent Development Table 75. Octapharma Company Information Table 76. Octapharma Business Overview Table 77. Octapharma 4 Factor Pro-thrombin Complex Concentrate Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Octapharma 4 Factor Pro-thrombin Complex Concentrate Product Portfolio Table 79. Octapharma Recent Development Table 80. CSL Behring Company Information Table 81. CSL Behring Business Overview Table 82. CSL Behring 4 Factor Pro-thrombin Complex Concentrate Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. CSL Behring 4 Factor Pro-thrombin Complex Concentrate Product Portfolio Table 84. CSL Behring Recent Development Table 85. Key Raw Materials Table 86. Raw Materials Key Suppliers Table 87. 4 Factor Pro-thrombin Complex Concentrate Distributors List Table 88. 4 Factor Pro-thrombin Complex Concentrate Customers List Table 89. Research Programs/Design for This Report Table 90. Authors List of This Report Table 91. Secondary Sources Table 92. Primary Sources List of Figures Figure 1. 4 Factor Pro-thrombin Complex Concentrate Product Image Figure 2. Global 4 Factor Pro-thrombin Complex Concentrate Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global 4 Factor Pro-thrombin Complex Concentrate Market Size (2021-2032) & (US$ Million) Figure 4. Global 4 Factor Pro-thrombin Complex Concentrate Sales (2021-2032) & (k units) Figure 5. Global 4 Factor Pro-thrombin Complex Concentrate Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 4 Factor Pro-thrombin Complex Concentrate Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Prothromplex Image Figure 9. Octaplex Image Figure 10. Cofact Image Figure 11. Beriplex Image Figure 12. Other Image Figure 13. Global 4 Factor Pro-thrombin Complex Concentrate Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global 4 Factor Pro-thrombin Complex Concentrate Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global 4 Factor Pro-thrombin Complex Concentrate Sales Market Share by Type (2021-2032) Figure 16. Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 17. Global 4 Factor Pro-thrombin Complex Concentrate Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global 4 Factor Pro-thrombin Complex Concentrate Revenue Market Share by Type (2021-2032) Figure 19. Hemophilia B Image Figure 20. Acquired Coagulation Factor Deficiency Image Figure 21. Global 4 Factor Pro-thrombin Complex Concentrate Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global 4 Factor Pro-thrombin Complex Concentrate Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global 4 Factor Pro-thrombin Complex Concentrate Sales Market Share by Application (2021-2032) Figure 24. Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global 4 Factor Pro-thrombin Complex Concentrate Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global 4 Factor Pro-thrombin Complex Concentrate Revenue Market Share by Application (2021-2032) Figure 27. North America 4 Factor Pro-thrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 28. North America 4 Factor Pro-thrombin Complex Concentrate Sales Market Share by Country (2021-2032) Figure 29. U.S. 4 Factor Pro-thrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 30. Canada 4 Factor Pro-thrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 31. Mexico 4 Factor Pro-thrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe 4 Factor Pro-thrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe 4 Factor Pro-thrombin Complex Concentrate Sales Market Share by Country (2021-2032) Figure 34. Germany 4 Factor Pro-thrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 35. France 4 Factor Pro-thrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 36. U.K. 4 Factor Pro-thrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 37. Italy 4 Factor Pro-thrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 38. Netherlands 4 Factor Pro-thrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific 4 Factor Pro-thrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific 4 Factor Pro-thrombin Complex Concentrate Sales Market Share by Country (2021-2032) Figure 41. China 4 Factor Pro-thrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 42. Japan 4 Factor Pro-thrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 43. South Korea 4 Factor Pro-thrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 44. Southeast Asia 4 Factor Pro-thrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 45. India 4 Factor Pro-thrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 46. Australia 4 Factor Pro-thrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa 4 Factor Pro-thrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa 4 Factor Pro-thrombin Complex Concentrate Sales Market Share by Country (2021-2032) Figure 49. Brazil 4 Factor Pro-thrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 50. South Africa 4 Factor Pro-thrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 51. Saudi Arabia 4 Factor Pro-thrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 52. Turkey 4 Factor Pro-thrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 53. Argentina 4 Factor Pro-thrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 54. UAE 4 Factor Pro-thrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 55. Egypt 4 Factor Pro-thrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 56. Chile 4 Factor Pro-thrombin Complex Concentrate Sales and Growth Rate (2021-2032) & (k units) Figure 57. Global 4 Factor Pro-thrombin Complex Concentrate Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global 4 Factor Pro-thrombin Complex Concentrate Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America 4 Factor Pro-thrombin Complex Concentrate Revenue (2021-2032) & (US$ Million) Figure 60. North America 4 Factor Pro-thrombin Complex Concentrate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe 4 Factor Pro-thrombin Complex Concentrate Revenue (2021-2032) & (US$ Million) Figure 62. Europe 4 Factor Pro-thrombin Complex Concentrate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific 4 Factor Pro-thrombin Complex Concentrate Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific 4 Factor Pro-thrombin Complex Concentrate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa 4 Factor Pro-thrombin Complex Concentrate Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa 4 Factor Pro-thrombin Complex Concentrate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. 4 Factor Pro-thrombin Complex Concentrate Value Chain Figure 68. Manufacturing Cost Structure Figure 69. 4 Factor Pro-thrombin Complex Concentrate Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Prothromplex
  • Octaplex
  • Cofact
  • Beriplex
  • Other
Applications
  • Hemophilia B
  • Acquired Coagulation Factor Deficiency
Companies covered
  • Takeda
  • Prothya Biosolutions
  • Octapharma
  • CSL Behring

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global 4 Factor Pro-thrombin Complex Concentrate Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global 4 Factor Pro-thrombin Complex Concentrate Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global 4 Factor Pro-thrombin Complex Concentrate Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global 4 Factor Pro-thrombin Complex Concentrate Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global 4 Factor Pro-thrombin Complex Concentrate Market Dynamics
  1. 2.1 4 Factor Pro-thrombin Complex Concentrate Industry Trends
  2. 2.2 4 Factor Pro-thrombin Complex Concentrate Industry Drivers
  3. 2.3 4 Factor Pro-thrombin Complex Concentrate Industry Opportunities and Challenges
  4. 2.4 4 Factor Pro-thrombin Complex Concentrate Industry Restraints
3 4 Factor Pro-thrombin Complex Concentrate Market by Manufacturers
  1. 3.1 Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Manufacturers (2021-2026)
  2. 3.2 Global 4 Factor Pro-thrombin Complex Concentrate Sales by Manufacturers (2021-2026)
  3. 3.3 Global 4 Factor Pro-thrombin Complex Concentrate Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global 4 Factor Pro-thrombin Complex Concentrate Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global 4 Factor Pro-thrombin Complex Concentrate Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global 4 Factor Pro-thrombin Complex Concentrate Manufacturers, Product Type & Application
  7. 3.7 Global 4 Factor Pro-thrombin Complex Concentrate Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global 4 Factor Pro-thrombin Complex Concentrate Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 4 Factor Pro-thrombin Complex Concentrate Players Market Share by Revenue in 2025
  11. 3.8.3 2025 4 Factor Pro-thrombin Complex Concentrate Tier 1, Tier 2, and Tier 3
4 4 Factor Pro-thrombin Complex Concentrate Market by Type
  1. 4.1 4 Factor Pro-thrombin Complex Concentrate Type Introduction
  2. 4.1.1 Prothromplex
  3. 4.1.2 Octaplex
  4. 4.1.3 Cofact
  5. 4.1.4 Beriplex
  6. 4.1.5 Other
  7. 4.2 Global 4 Factor Pro-thrombin Complex Concentrate Sales by Type
  8. 4.2.1 Global 4 Factor Pro-thrombin Complex Concentrate Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global 4 Factor Pro-thrombin Complex Concentrate Sales by Type (2021-2032)
  10. 4.2.3 Global 4 Factor Pro-thrombin Complex Concentrate Sales Market Share by Type (2021-2032)
  11. 4.3 Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Type
  12. 4.3.1 Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Type (2021-2032)
  14. 4.3.3 Global 4 Factor Pro-thrombin Complex Concentrate Revenue Market Share by Type (2021-2032)
5 4 Factor Pro-thrombin Complex Concentrate Market by Application
  1. 5.1 4 Factor Pro-thrombin Complex Concentrate Application Introduction
  2. 5.1.1 Hemophilia B
  3. 5.1.2 Acquired Coagulation Factor Deficiency
  4. 5.2 Global 4 Factor Pro-thrombin Complex Concentrate Sales by Application
  5. 5.2.1 Global 4 Factor Pro-thrombin Complex Concentrate Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global 4 Factor Pro-thrombin Complex Concentrate Sales by Application (2021-2032)
  7. 5.2.3 Global 4 Factor Pro-thrombin Complex Concentrate Sales Market Share by Application (2021-2032)
  8. 5.3 Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Application
  9. 5.3.1 Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Application (2021-2032)
  11. 5.3.3 Global 4 Factor Pro-thrombin Complex Concentrate Revenue Market Share by Application (2021-2032)
6 Global 4 Factor Pro-thrombin Complex Concentrate Sales by Region
  1. 6.1 Global 4 Factor Pro-thrombin Complex Concentrate Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global 4 Factor Pro-thrombin Complex Concentrate Sales by Region (2021-2032)
  3. 6.2.1 Global 4 Factor Pro-thrombin Complex Concentrate Sales by Region (2021-2026)
  4. 6.2.2 Global 4 Factor Pro-thrombin Complex Concentrate Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America 4 Factor Pro-thrombin Complex Concentrate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America 4 Factor Pro-thrombin Complex Concentrate Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe 4 Factor Pro-thrombin Complex Concentrate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe 4 Factor Pro-thrombin Complex Concentrate Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific 4 Factor Pro-thrombin Complex Concentrate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific 4 Factor Pro-thrombin Complex Concentrate Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa 4 Factor Pro-thrombin Complex Concentrate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa 4 Factor Pro-thrombin Complex Concentrate Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Region
  1. 7.1 Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Region
  2. 7.1.1 Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Region (2021-2026)
  4. 7.1.3 Global 4 Factor Pro-thrombin Complex Concentrate Revenue by Region (2027-2032)
  5. 7.1.4 Global 4 Factor Pro-thrombin Complex Concentrate Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America 4 Factor Pro-thrombin Complex Concentrate Revenue (2021-2032)
  8. 7.2.2 North America 4 Factor Pro-thrombin Complex Concentrate Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe 4 Factor Pro-thrombin Complex Concentrate Revenue (2021-2032)
  11. 7.3.2 Europe 4 Factor Pro-thrombin Complex Concentrate Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific 4 Factor Pro-thrombin Complex Concentrate Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific 4 Factor Pro-thrombin Complex Concentrate Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa 4 Factor Pro-thrombin Complex Concentrate Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa 4 Factor Pro-thrombin Complex Concentrate Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda 4 Factor Pro-thrombin Complex Concentrate Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda 4 Factor Pro-thrombin Complex Concentrate Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 Prothya Biosolutions
  8. 8.2.1 Prothya Biosolutions Company Information
  9. 8.2.2 Prothya Biosolutions Business Overview
  10. 8.2.3 Prothya Biosolutions 4 Factor Pro-thrombin Complex Concentrate Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Prothya Biosolutions 4 Factor Pro-thrombin Complex Concentrate Product Portfolio
  12. 8.2.5 Prothya Biosolutions Recent Developments
  13. 8.3 Octapharma
  14. 8.3.1 Octapharma Company Information
  15. 8.3.2 Octapharma Business Overview
  16. 8.3.3 Octapharma 4 Factor Pro-thrombin Complex Concentrate Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Octapharma 4 Factor Pro-thrombin Complex Concentrate Product Portfolio
  18. 8.3.5 Octapharma Recent Developments
  19. 8.4 CSL Behring
  20. 8.4.1 CSL Behring Company Information
  21. 8.4.2 CSL Behring Business Overview
  22. 8.4.3 CSL Behring 4 Factor Pro-thrombin Complex Concentrate Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 CSL Behring 4 Factor Pro-thrombin Complex Concentrate Product Portfolio
  24. 8.4.5 CSL Behring Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 4 Factor Pro-thrombin Complex Concentrate Value Chain Analysis
  2. 9.1.1 4 Factor Pro-thrombin Complex Concentrate Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 4 Factor Pro-thrombin Complex Concentrate Production Mode & Process
  6. 9.2 4 Factor Pro-thrombin Complex Concentrate Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 4 Factor Pro-thrombin Complex Concentrate Distributors
  9. 9.2.3 4 Factor Pro-thrombin Complex Concentrate Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst